Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells.
about
Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells.The induction of tolerance by dendritic cells that have captured apoptotic cellsLigation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activationDendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial productsIdentification of proteases employed by dendritic cells in the processing of protein purified derivative (PPD)Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future TherapiesDendritic Cells in Oncolytic Virus-Based Anti-Cancer TherapyImmunological cells and functions in Gaucher diseaseRegulatory dendritic cells for immunotherapy in immunologic diseasesEfficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alphaLangerhans cells but not monocytes are capable of antigen presentation in vitro in corticosteroid contact hypersensitivityIdentification and expression of mouse Langerin (CD207) in dendritic cellsEfficacy of imiquimod-based transcutaneous immunization using a nano-dispersed emulsion gel formulationMature dendritic cells use endocytic receptors to capture and present antigensRole of dendritic cells in the immune response induced by mouse mammary tumor virus superantigen.Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein.Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization.Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancersAvoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance.Langerhans cells as targets for immunotherapy against skin cancer.Dendritic cells continue to capture and present antigens after maturation in vivo.Mature T cell seeks antigen for meaningful relationship in lymph node.Microchimerism, dendritic cell progenitors and transplantation toleranceFunctional dichotomy between Langerhans cells that present antigen to naive and to memory/effector T lymphocytes.Polymyxin B inadequately quenches the effects of contaminating lipopolysaccharide on murine dendritic cells.Langerhans cells are not required for graft-versus-host disease.Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?Targeting epidermal Langerhans cells by epidermal powder immunization.Viral interleukin-10 expressed by human cytomegalovirus during the latent phase of infection modulates latently infected myeloid cell differentiation.Increased number of Langerhans cells in the epidermis of diabetic foot ulcers correlates with healing outcome.Depletion of Langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of E-cadherin.Modulation of dendritic cell immunobiology via inhibition of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase.Some interfaces of dendritic cell biology.Langerhans cells - dendritic cells of the epidermis.Borrelia burgdorferi-pulsed dendritic cells induce a protective immune response against tick-transmitted spirochetes.Synthesis, stability, and subcellular distribution of major histocompatibility complex class II molecules in Langerhans cells infected with Leishmania major.Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cellsPreferential infection of dendritic cells during human immunodeficiency virus type 1 infection of blood leukocytes.Dendritic cell maturation and antigen presentation in the absence of invariant chain.Basic concepts of immune response and defense development.
P2860
Q24604092-E7BF07B4-A69F-48F1-985D-510252C01DE2Q24671078-3F5B5235-BDE4-489E-A850-073E5BD8F369Q24677534-BC593BEE-BF5C-4DA6-B884-E154FD290A29Q24678867-E98E14EE-75CC-479D-8493-9EBE8D358CFAQ24803671-7B04C07D-F0E4-4FDB-BF46-559AA8205DB1Q26752558-C0FAA4F1-376E-4B0D-994B-775F7529B4B3Q26774345-4FC0E868-FEB2-4BEF-B260-406A81630C6FQ26827675-54EBE432-2E66-44C8-87C5-71AD32016DF5Q26866216-2E51BD6F-DA11-4363-8846-207AFB69DEF4Q28251443-2943BE5F-FDE8-44DB-A245-344FBE4CC47AQ28332412-23F411BA-D162-4BD5-92FC-7C47ED5C8959Q28507435-970FC661-EEA5-4FEA-8A25-C2CD7C4EB5C4Q28540777-70FA87A5-07D2-4B86-8B7F-7C1156639AFDQ30493720-2F3A4F30-3B51-41E4-848E-C33B82DF74F1Q33820167-D02CE94E-A6BE-450E-B000-9539DDB87FDAQ33829192-0360F834-45C4-4BB7-9B92-A65A1243DBDFQ33874509-1CD9F195-E972-463A-B78D-606A3D31FA05Q33890381-2C9D0203-A8A6-435C-B93F-B55C21633C5FQ33897693-4514DAFD-3CB8-4277-B21D-BB42A55AC7B2Q34009436-E1DF52B2-6451-4A2F-9508-4396835CDAB6Q34084191-EF88661B-D331-4AB1-AFB3-BC5D0F2357C7Q34235880-79F00F2F-03AB-4B7F-8D32-53894448226AQ34239907-9AAE7943-B98B-457F-BCFD-6F4F1317CA9AQ34274604-DD4478A3-28FD-46B1-BB9C-383E1D458E78Q34279861-1E2E3AC3-7102-45FD-931F-8E4C6E3CFA5BQ34542158-B94CA005-CFCC-4665-B195-CEF028D088FEQ34669820-080455BE-1DE9-4D7E-9FA2-11DD45B8F939Q34740663-AED79B10-FF7D-42F8-B309-016F16C0A78BQ35077780-9AE8173E-38C3-4662-A63D-140D56DDCC4AQ35146488-27B4CFB3-0268-4837-91BB-C4C1A98DFDACQ35155315-5FE42E7D-B628-4428-9125-C3C6800D2357Q35205220-82DC624F-85E0-44F6-B6A5-38D8FDBAFB81Q35219290-74B49428-2635-4DE6-AF0D-1C4A917D5BF8Q35219303-3FEE2B6B-7736-43D9-9F48-6729C98F327EQ35553432-2084E6F5-6402-4585-81C1-FC6B73426B11Q35553745-A60BA780-16D9-482C-BA3B-F6B91F2EFD2CQ35764615-A9C7451D-F979-425D-BAD0-7E5354DC1240Q35784640-A642139D-1748-4577-8E8C-6318D08B8A72Q35789511-D76C4E0E-9E2D-4A17-8299-2224F8AE0044Q36161895-82442704-6D1B-4AD9-988A-DBE8E1D5B044
P2860
Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Presentation of exogenous prot ...... e, epidermal Langerhans cells.
@ast
Presentation of exogenous prot ...... e, epidermal Langerhans cells.
@en
type
label
Presentation of exogenous prot ...... e, epidermal Langerhans cells.
@ast
Presentation of exogenous prot ...... e, epidermal Langerhans cells.
@en
prefLabel
Presentation of exogenous prot ...... e, epidermal Langerhans cells.
@ast
Presentation of exogenous prot ...... e, epidermal Langerhans cells.
@en
P2093
P2860
P356
P1476
Presentation of exogenous prot ...... e, epidermal Langerhans cells.
@en
P2093
A M Livingstone
C G Fathman
M Witmer-Pack
R M Steinman
P2860
P304
P356
10.1084/JEM.169.3.1169
P407
P577
1989-03-01T00:00:00Z